Robuta

https://vivos.com/ Vivos Therapeutics, Inc. - Non-Surgical Solution for Obstructive Sleep Apnea Apr 24, 2026 - To Breathe Well is to Live Fully The only FDA-cleared oral appliance alternative to CPAP for moderate to severe OSA. No Masks. No Surgery. No Lifetime... therapeutics incnon surgicalobstructive sleepvivossolution https://progenicytetherapeuticsinc.com/ Progenicyte Therapeutics, Inc. - Down Syndrome, Alzheimer's Therapy, Stem Cell Hair Products, Stem... Progenicyte develops innovative technology using stem cell therapy technology. We are in fore front of developing a future Alzheimer's Therapy that is unmet... stem cell hairtherapeutics incsyndromealzheimertherapy https://femtech.ca/company/spm-therapeutics-inc/ SPM Therapeutics inc - Femtech Canada Oct 29, 2025 - SPM Therapeutics is developing a new class of therapeutics based on natural MARESIN compounds that resolve inflammation at its source. Its patented lead... therapeutics incspmfemtechcanada https://investors.atossatherapeutics.com/sec-filings Atossa Therapeutics, Inc. | SEC Filings therapeutics incsecfilings https://investors.atossatherapeutics.com/faqs Atossa Therapeutics, Inc. | FAQs therapeutics incfaqs https://www.sangamo.com/ Sangamo Therapeutics, Inc. | Pioneering Genetic Cures May 12, 2026 - Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene... therapeutics incpioneeringgeneticcures https://genomefrontier.com/ Home - GenomeFrontier Therapeutics, Inc. 先驅生技 therapeutics inc https://www.tallactherapeutics.com/ Tallac Therapeutics, Inc – Landing page therapeutics inclanding https://rss.investorbrandnetwork.com/bmw/biomednewsbreaks-oncotelic-therapeutics-inc-otcqb-otlc-completes-12-5m-n2b-asset-transfer-to-lunai-bioworks/ BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Completes $12.5M N2B Asset Transfer... therapeutics incotcqbcompletesassettransfer https://www.diamedica.com/ DiaMedica Therapeutics, Inc. (DMAC) DiaMedica Therapeutics is a biopharmaceutical company that specializes in creating synthetic proteins to treat a variety of conditions. therapeutics incdmac https://www.networknewswire.com/networknewsbreaks/networknewsbreaks-oncotelic-therapeutics-inc-otcqb-otlc-completes-12-5m-n2b-asset-transfer-to-lunai-bioworks/ NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Completes $12.5M N2B Asset Transfer... May 6, 2026 - Oncotelic Therapeutics (OTCQB: OTLC) announced the consummation of a strategic asset transfer agreement with Lunai Bioworks, Inc., granting worldwide rights to... therapeutics incotcqbcompletesassettransfer https://investors.atossatherapeutics.com/stock-quote-chart Atossa Therapeutics, Inc. | Stock Quote & Chart therapeutics incstock quotechart https://layoffalert.org/company/sangamo-therapeutics-inc Sangamo Therapeutics, Inc. Layoffs: WARN Act Notices & History | LayoffAlert.org | LayoffAlert.org Track 2 WARN Act layoff notices for Sangamo Therapeutics, Inc.. 74 employees affected across 1 state. Complete layoff history with dates, locations, and... inc layoffs warnact notices historytherapeuticslayoffalert https://layoffalert.org/company/sorrento-therapeutics-inc Sorrento Therapeutics, Inc. Layoffs: WARN Act Notices & History | LayoffAlert.org | LayoffAlert.org Track 2 WARN Act layoff notices for Sorrento Therapeutics, Inc.. 30 employees affected across 1 state. Complete layoff history with dates, locations, and... inc layoffs warnact notices historysorrentotherapeuticslayoffalert https://www.cypriumtx.com/ Cyprium Therapeutics Inc. | Developing new therapeutics for rare pediatric diseases therapeutics incdeveloping newrarepediatricdiseases https://www.globenewswire.com/news-release/2021/04/27/2217269/0/en/Protagenic-Therapeutics-Inc-Announces-Nasdaq-Uplisting-and-Pricing-of-13-2-Million-Public-Offering.html Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting Apr 27, 2021 - New York, April 26, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ( therapeutics incannouncesnasdaq https://atossatherapeutics.com/endoxifen-program-for-duchenne/ Atossa Therapeutics, Inc | Atossa Therapeutics | Announces New Endoxifen Program in Duchenne... Atossa Therapeutics is initiating a new research and development program to explore its investigational oral therapy, endoxifen, as a potential treatment for... therapeutics incannounces newprogramduchenne https://investors.atossatherapeutics.com/overview Atossa Therapeutics, Inc. | Investors therapeutics incinvestors https://www.relmada.com/ Relmada Therapeutics, Inc. (RLMD) therapeutics inc https://ir.avenuetx.com/ Avenue Therapeutics, Inc. (ATXI) Avenue Therapeutics, Inc. (OTC: ATXI) is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of... therapeutics incavenue https://www.nuot.com/ Nuo Therapeutics, Inc. Hardwired for Healing. Aimed for Impact. Jun 7, 2022 - Nuo Therapeutics is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative... therapeutics incnuohardwiredhealingaimed https://www.xortx.com/ XORTX Therapeutics Inc. (XRTX) therapeutics inc https://www.tip.us/tips/otlc.php Oncotelic Therapeutics Inc. (OTCQB: OTLC) Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company developing RNA-based, immunotherapy, and targeted therapeutics for... therapeutics incotcqb https://ir.dwtx.com/ Investor Relations :: Dogwood Therapeutics, Inc. (DWTX) Dogwood Therapeutics (Nasdaq DWTX) is a development-stage biotechnology company focused on advancing novel therapeutics for pain and neuropathy. Dogwood’s lead... investor relationstherapeutics incdogwood https://endotherapeutics.com/ Endo-Therapeutics, Inc. – Think Within Let's Work Together We provide full-service support to deliver the highest quality medical devices to the marketplace. Who We Are Endo-Therapeutics is a... therapeutics incendothinkwithin https://www.qualitystocks.com/qualitystocksnewsbreaks-oncotelic-therapeutics-inc-otcqb-otlc-completes-12-5m-n2b-asset-transfer-to-lunai-bioworks/ QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Completes $12.5M N2B Asset... May 6, 2026 - Oncotelic Therapeutics (OTCQB: OTLC) announced the consummation of a strategic asset transfer agreement with Lunai Bioworks, Inc., granting worldwide rights to... therapeutics incqualitystocksnewsbreaksotcqbcompletesasset https://www.insidermonkey.com/insider-trading/company/gyre+therapeutics+inc/1124105/ Gyre Therapeutics Inc. (GYRE) - Insider Monkey Gyre Therapeutics Inc. (GYRE) latest news, insider trading and hedge fund ownership data provided by Insider Monkey. therapeutics incinsidermonkey https://www.prnewswire.com/news-releases/coeptis-therapeutics-inc-announces-closing-of-business-combination-with-bull-horn-holdings-corp-301662851.html Coeptis Therapeutics, Inc. Announces Closing of Business Combination with Bull Horn Holdings Corp. Oct 31, 2022 - /PRNewswire/ -- Coeptis Therapeutics, Inc. ( inc announces closingtherapeuticsbusinesscombinationbull https://www.sigyntherapeutics.com/ Sigyn Therapeutics, Inc. (SIGY) therapeutics inc https://atossatherapeutics.com/contact-us/ Atossa Therapeutics, Inc | Atossa Therapeutics | Contact Us Atossa Therapeutics 10202 5th Ave NE, Suite 200 Seattle, WA 98125 1 (206) 588-0256 info@atossainc.com therapeutics incus https://ir.unicycive.com/ Investor Relations :: Unicycive Therapeutics, Inc. (UNCY) Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum... investor relationstherapeutics inc https://www.redchip.com/stocks/FDMT 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) Stock Information | RedChip 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) therapeutics incstock informationmolecularnasdaqredchip https://layoffalert.org/company/poseida-therapeutics-inc Poseida Therapeutics, Inc. Layoffs: WARN Act Notices & History | LayoffAlert.org | LayoffAlert.org Track 1 WARN Act layoff notices for Poseida Therapeutics, Inc.. 52 employees affected across 1 state. Complete layoff history with dates, locations, and... inc layoffs warnact notices historytherapeuticslayoffalert https://www.prnewswire.com/news-releases/hoth-therapeutics-inc-announces-pricing-of-7-0-million-underwritten-public-offering-priced-at-the-market-301523407.html Hoth Therapeutics, Inc. Announces Pricing of $7.0 Million Underwritten Public Offering Priced... Apr 11, 2022 - /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the pricing of its underwritten public... therapeutics incannounces pricingpublic offeringhothmillion https://atossatherapeutics.com/expanded-access/ Atossa Therapeutics, Inc | Atossa Therapeutics | Contact Us Atossa Therapeutics 10202 5th Ave NE, Suite 200 Seattle, WA 98125 1 (206) 588-0256 info@atossainc.com therapeutics incus https://www.quiverquant.com/stock/GYRE/financials/ GYRE | Gyre Therapeutics, Inc. Common Financials - Income Statement View quarterly income statements for Gyre Therapeutics, Inc. Common Stock (GYRE). See revenue, expenses, and profit or loss for the most recent quarter. therapeutics inccommonfinancialsincomestatement https://atossatherapeutics.com/science/ Atossa Therapeutics, Inc | Atossa Therapeutics | The Sciece of (Z)-endoxifen (Z)-endoxifen is a next-generation selective estrogen receptor modulator (SERM) engineered to deliver almost 100-fold greater potency than existing SERMs,... therapeutics inc https://fminus.org/clients/celldex-therapeutics-inc/ CELLDEX THERAPEUTICS, INC. | F Minus therapeutics incminus https://atossatherapeutics.com/legal/ Atossa Therapeutics, Inc | Legal therapeutics inclegal https://zlk.com/cases/aldeyra-therapeutics-inc-lawsuit-submission-form Aldeyra Therapeutics, Inc. Class Action Lawsuit – ALDX | Levi & Korsinsky inc class actiontherapeuticslawsuitlevikorsinsky https://investors.atossatherapeutics.com/governance-documents Atossa Therapeutics, Inc. | Governance Documents therapeutics incgovernancedocuments https://fminus.org/clients/biosplice-therapeutics-inc/ BIOSPLICE THERAPEUTICS, INC. | F Minus therapeutics incminus https://sentynl.com/privacy/ Privacy - Sentynl Therapeutics, Inc. Sentynl Privacy Statement Effective Date: May 18, 2020 Updated Date: March 11, 2025 Sentynl Therapeutics, Inc. (“Sentynl,” “We” or “Our”) are committed to... sentynl therapeuticsprivacyinc https://gelsanatherapeutics.com/ Home - GelSana Therapeutics, Inc. Apr 30, 2026 - We are Redefining Wound Healing Calming overactive inflammation with zwitterionic technology that kickstarts the body’s natural wound healing. CleraFlexTM therapeuticsinc https://sentynl.com/contact/ Contact - Sentynl Therapeutics, Inc. Contact We Look Forward to Connecting With You For business development, please visit our Business Development page. To report an adverse event or product... sentynl therapeuticsinc https://www.deciduoustx.com/ Home - Deciduous Therapeutics Inc. deciduoustherapeuticsinc https://myrtellegtx.com/ Myrtelle, Inc. - The Future of Genetic Therapeutics Myrtelle is a patient-centered, innovation-driven gene therapy company transforming the treatment of neurological diseases. incfuturegenetictherapeutics https://sentynl.com/terms-of-use/ Terms of Use - Sentynl Therapeutics, Inc. Terms of Use Effective: November 23, 2015 Updated Date: November 6, 2023 This Terms of Use Agreement and our Privacy Statement (together, these “Terms”)... sentynl therapeuticstermsuseinc https://www.tscan.com/privacy-policy/ Privacy Policy - TScan Therapeutics, Inc. May 14, 2026 - Privacy Policy Effective date: June 8, 2025 At TScan Therapeutics, Inc. (“TScan”) we know you care about how your Personal Data is used and shared, and we take... privacy policytscantherapeuticsinc https://www.renatherapeutics.com/ レナセラピューティクス株式会社│Rena Therapeutics Inc. レナセラピューティクス株式会社は、横田隆徳教授らにより開発されたヘテロ核酸技術を第3のプラットフォーム技術として確立し、新しい核酸医薬品の創製を目的とした東京医科歯科大学発のバイオベンチャー企業です。 therapeuticsinc https://sentynl.com/ Home - Sentynl Therapeutics, Inc. Sentynl Therapeutics, Inc. is a US-based specialty pharmaceutical company dedicated to improving patient care through innovative therapeutics. sentynl therapeuticsinc https://www.phanesthera.com/about-us/leadership-team/ Leadership Team - Phanes Therapeutics, Inc Jul 24, 2023 - About Us Leadership Team Scientific Advisory Board Clinical Advisory Board Ming Wang, PhD, MBA President and CEO Dr. Ming Wang is Founder, President and CEO of... leadership teamphanestherapeuticsinc https://aboutmocdtypea.com/ About MoCD Type A | Rare Disease Education By Sentynl Therapeutics, Inc. MoCD Type A is a treatable disease that often appears in the first weeks of life with seizures | Info by Sentynl Therapeutics, Inc. rare diseasesentynl therapeuticstypeeducationinc